204 related articles for article (PubMed ID: 12575734)
1. Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model.
van der Lubben IM; van Opdorp FA; Hengeveld MR; Onderwater JJ; Koerten HK; Verhoef JC; Borchard G; Junginger HE
J Drug Target; 2002 Sep; 10(6):449-56. PubMed ID: 12575734
[TBL] [Abstract][Full Text] [Related]
2. In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry.
Van Der Lubben IM; Konings FA; Borchard G; Verhoef JC; Junginger HE
J Drug Target; 2001; 9(1):39-47. PubMed ID: 11378522
[TBL] [Abstract][Full Text] [Related]
3. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
van der Lubben IM; Verhoef JC; van Aelst AC; Borchard G; Junginger HE
Biomaterials; 2001 Apr; 22(7):687-94. PubMed ID: 11246962
[TBL] [Abstract][Full Text] [Related]
4. A comparison of three Peyer's patch "M-like" cell culture models: particle uptake, bacterial interaction, and epithelial histology.
Ahmad T; Gogarty M; Walsh EG; Brayden DJ
Eur J Pharm Biopharm; 2017 Oct; 119():426-436. PubMed ID: 28754262
[TBL] [Abstract][Full Text] [Related]
5. Microparticle transport in the human intestinal M cell model.
Lai YH; D'Souza MJ
J Drug Target; 2008 Jan; 16(1):36-42. PubMed ID: 18172818
[TBL] [Abstract][Full Text] [Related]
6. Chitosan for mucosal vaccination.
van der Lubben IM; Verhoef JC; Borchard G; Junginger HE
Adv Drug Deliv Rev; 2001 Nov; 52(2):139-44. PubMed ID: 11718937
[TBL] [Abstract][Full Text] [Related]
7. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.
Jiang T; Singh B; Li HS; Kim YK; Kang SK; Nah JW; Choi YJ; Cho CS
Biomaterials; 2014 Feb; 35(7):2365-73. PubMed ID: 24342722
[TBL] [Abstract][Full Text] [Related]
8. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of chitosan microparticles intended for controlled drug delivery.
Ko JA; Park HJ; Hwang SJ; Park JB; Lee JS
Int J Pharm; 2002 Dec; 249(1-2):165-74. PubMed ID: 12433445
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and gut associated lymphoid tissue translocation of polymyxin B orally administered by alginate/chitosan microparticles in rats.
Coppi G; Bondi M; Coppi A; Rossi T; Sergi S; Iannuccelli V
J Pharm Pharmacol; 2008 Jan; 60(1):21-6. PubMed ID: 18088501
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
12. Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue.
Fujimura Y; Akisada T; Harada T; Haruma K
Med Mol Morphol; 2006 Dec; 39(4):181-6. PubMed ID: 17187179
[TBL] [Abstract][Full Text] [Related]
13. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting.
Frey A; Giannasca KT; Weltzin R; Giannasca PJ; Reggio H; Lencer WI; Neutra MR
J Exp Med; 1996 Sep; 184(3):1045-59. PubMed ID: 9064322
[TBL] [Abstract][Full Text] [Related]
14. Permeability measurement of macromolecules and assessment of mucosal antigen sampling using in vitro converted M cells.
Liang E; Kabcenell AK; Coleman JR; Robson J; Ruffles R; Yazdanian M
J Pharmacol Toxicol Methods; 2001; 46(2):93-101. PubMed ID: 12481846
[TBL] [Abstract][Full Text] [Related]
15. In vitro and ex vivo characterization of lectin-labeled Mycobacterium tuberculosis antigen-containing microspheres for enhanced oral delivery.
Yeboah KG; Akande J; Addo RT; Siwale RC; Aninkorah-Yeboah K; Siddig A
J Drug Target; 2014 Jan; 22(1):34-47. PubMed ID: 23987115
[TBL] [Abstract][Full Text] [Related]
16. Targeting antigens to murine and human M-cells with Aleuria aurantia lectin-functionalized microparticles.
Roth-Walter F; Bohle B; Schöll I; Untersmayr E; Scheiner O; Boltz-Nitulescu G; Gabor F; Brayden DJ; Jensen-Jarolim E
Immunol Lett; 2005 Sep; 100(2):182-8. PubMed ID: 15913790
[TBL] [Abstract][Full Text] [Related]
17. [Oral vaccination and vaccine-entrapped microparticle delivery system].
Li FQ; Fei YB; Su H; Hu JH
Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
[TBL] [Abstract][Full Text] [Related]
18. Microparticulate polyelectrolyte complexes for gentamicin transport across intestinal epithelia.
Iannuccelli V; Montanari M; Bertelli D; Pellati F; Coppi G
Drug Deliv; 2011 Jan; 18(1):26-37. PubMed ID: 20726809
[TBL] [Abstract][Full Text] [Related]
19. Morphological aspects of interactions between microparticles and mammalian cells: intestinal uptake and onward movement.
Carr KE; Smyth SH; McCullough MT; Morris JF; Moyes SM
Prog Histochem Cytochem; 2012 Jan; 46(4):185-252. PubMed ID: 22240063
[TBL] [Abstract][Full Text] [Related]
20. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
